Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
22%
Ph phase_4
3
33%
Ph phase_1
1
11%
Ph phase_3
1
11%

Phase Distribution

1

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
1(14.3%)
Phase 3Large-scale testing
1(14.3%)
Phase 4Post-market surveillance
3(42.9%)
N/ANon-phased studies
2(28.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(7)
Other(2)

Detailed Status

Completed7
unknown2

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (14.3%)
Phase 31 (14.3%)
Phase 43 (42.9%)
N/A2 (28.6%)

Trials by Status

unknown222%
completed778%

Recent Activity

0 active trials
Showing 5 of 9
completedphase_3

Start or STop Anticoagulants Randomised Trial (SoSTART)

NCT03153150
completednot_applicable

Effectiveness of a Multidisciplinary Medication Review With Follow-up for Patients Treated With Coumarin Anticoagulants in Primary Care

NCT03154489
unknown

Dabigatran Study in the Early Phase of Stroke. New Neuroimaging Markers and Biomarkers Study (SEDMAN STUDY)

NCT02742480
unknownphase_4

Rule Out Transcatheter Aortic Valve Thrombosis With Post Implantation Computed Tomography (RETORIC)

NCT02826200
completed

Pharmacogenetic Dosage Algorithm for Acenocoumarol

NCT03015025
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT03153150Phase 3

Start or STop Anticoagulants Randomised Trial (SoSTART)

Completed
NCT03154489Not Applicable

Effectiveness of a Multidisciplinary Medication Review With Follow-up for Patients Treated With Coumarin Anticoagulants in Primary Care

Completed
NCT02742480

Dabigatran Study in the Early Phase of Stroke. New Neuroimaging Markers and Biomarkers Study (SEDMAN STUDY)

Unknown
NCT02826200Phase 4

Rule Out Transcatheter Aortic Valve Thrombosis With Post Implantation Computed Tomography (RETORIC)

Unknown
NCT03015025

Pharmacogenetic Dosage Algorithm for Acenocoumarol

Completed
NCT01851824Phase 1

A Study of the Effect of Vemurafenib on the Pharmacokinetics of Acenocoumarol in Patients With BRAFV600 Mutation-Positive Metastatic Malignancy

Completed
NCT00711308Phase 4

Tinzaparin in the Treatment of the Acute Pulmonary Embolism

Completed
NCT00689520Phase 4

Long-Term Low-Molecular-Weight Heparin Versus Oral Anticoagulants in Deep Venous Thrombosis

Completed
NCT00512928Not Applicable

Safety Study of Vitamin K2 During Anticoagulation in Human Volunteers

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9